1. Home
  2. MSM vs BLTE Comparison

MSM vs BLTE Comparison

Compare MSM & BLTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MSC Industrial Direct Company Inc.

MSM

MSC Industrial Direct Company Inc.

N/A

Current Price

$119.51

Market Cap

7.0B

Sector

Industrials

ML Signal

N/A

Logo Belite Bio Inc

BLTE

Belite Bio Inc

N/A

Current Price

$151.61

Market Cap

6.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MSM
BLTE
Founded
1941
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.0B
6.0B
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
MSM
BLTE
Price
$119.51
$151.61
Analyst Decision
Hold
Strong Buy
Analyst Count
6
7
Target Price
$96.20
$198.00
AVG Volume (30 Days)
557.9K
147.0K
Earning Date
04-01-2026
05-08-2026
Dividend Yield
3.45%
N/A
EPS Growth
N/A
N/A
EPS
3.12
N/A
Revenue
$3,363,817,000.00
N/A
Revenue This Year
$5.82
N/A
Revenue Next Year
$5.26
$492.11
P/E Ratio
$39.11
N/A
Revenue Growth
4.99
N/A
52 Week Low
$78.80
$62.18
52 Week High
$130.46
$200.00

Technical Indicators

Market Signals
Indicator
MSM
BLTE
Relative Strength Index (RSI) 47.70 44.35
Support Level $118.14 $146.94
Resistance Level $127.25 $161.17
Average True Range (ATR) 2.89 7.15
MACD -0.16 -1.67
Stochastic Oscillator 40.07 4.70

Price Performance

Historical Comparison
MSM
BLTE

About MSM MSC Industrial Direct Company Inc.

Founded in 1941, MSC Industrial Direct originally manufactured and sold cutting tools to metalworking shops in New York. Through a series of acquisitions and organic expansions, MSC has grown into an industrial distribution powerhouse with a focus on specialized metalworking products and services. The firm also distributes a wide breadth of maintenance, repair, and operations supplies. MSC primarily operates in North America, where it derives over 95% of its revenue.

About BLTE Belite Bio Inc

Belite Bio Inc is a clinical stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases which have unmet medical need such as Geographic Atrophy (GA), the late atrophic (dry) form of age-related macular degeneration (AMD), and Stargardt disease type 1 (STGD1). In addition to its product candidate (tinlarebant) which is intended for the treatment of GA and STGD1, its drug development pipeline also includes a small molecule, orally administered compound, LBS-009, which is intended for the treatment of metabolic diseases such as non-alcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), type 2 diabetes (T2D), and gout.

Share on Social Networks: